Skip to main content
TipRanks
Go Ultimate75% OFF

InDex Pharmaceuticals Holding AB (FLERIE) Income Statement

2 Followers

InDex Pharmaceuticals Holding AB Income Statement

Last quarter (Q3 2026), InDex Pharmaceuticals Holding AB's total revenue was kr900.00K, an increase of 106.00% from the same quarter last year. In Q3, InDex Pharmaceuticals Holding AB's net income was kr-280.60M. See InDex Pharmaceuticals Holding AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
kr 8.80Mkr 100.00Kkr 97.50Mkr 0.00kr 0.00
kr -12.70Mkr -41.60Mkr 93.35Mkr -1.07Mkr -1.25M
kr 769.40Mkr 275.10Mkr 200.71Mkr 150.05Mkr 114.38M
Depreciation and Amortizationkr 600.00Kkr 800.00Kkr 1.22Mkr 1.07Mkr 1.25M
kr -743.60Mkr -225.70Mkr -93.82Mkr -99.15Mkr -101.66M
kr -782.10Mkr -110.80Mkr -107.37Mkr -151.11Mkr -115.63M
kr 24.20Mkr -117.10Mkr 12.10Mkr 50.78Mkr 12.59M
kr -757.90Mkr -227.90Mkr -95.27Mkr -100.33Mkr -103.04M
kr -756.90Mkr -228.00Mkr -95.27Mkr -100.33Mkr -103.04M
Per Share Metrics
Basic EPSkr -9.71kr -3.24kr -17.88kr -18.84kr -21.32
Diluted EPSkr -9.71kr -3.24kr -17.88kr -18.84kr -21.32
Weighted Average Shares Outstanding77.95M70.47M53.27M53.27M48.34M
Weighted Average Shares Outstanding (Diluted)77.95M70.47M53.27M53.27M48.34M

Currency in SEK

InDex Pharmaceuticals Holding AB Earnings and Revenue History

-800M-400M0400M-240000 %-160000 %-80000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin